# Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms

> **NCT03763253** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Imperial College London** · enrollment: 433 (actual)

## Conditions studied

- Prostate Cancer
- Metastatic Prostate Cancer

## Interventions

- **COMBINATION_PRODUCT:** Standard of Care
- **PROCEDURE:** Minimally Invasive Ablative Therapy (MIAT)
- **PROCEDURE:** Radical Therapy (Prostatectomy or Radiotherapy)

## Key facts

- **NCT ID:** NCT03763253
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-04-10
- **Primary completion:** 2026-08-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 433 (ACTUAL)
- **Last updated:** 2025-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03763253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03763253, "Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03763253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*